Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension.
Zhang T, Liang Z, Lin T, Cohen DJ, Arrieta A, Wang X, Qin X, Wang B, Huo Y, Liu GG, Jiang J, Zhang Z.
Zhang T, et al.
BMC Med. 2022 Oct 25;20(1):407. doi: 10.1186/s12916-022-02601-z.
BMC Med. 2022.
PMID: 36280851
Free PMC article.
Clinical Trial.
A probabilistic sensitivity analysis demonstrated that enalapril-folic acid compared with enalapril would be economically attractive in 74.5% of simulations at a threshold of $37,663 (242,9281 RMB) per QALY (3x current Chinese per capita GDP). Several high-risk subgroups h …
A probabilistic sensitivity analysis demonstrated that enalapril-folic acid compared with enalapril would be economically attractive in 74.5 …